Maravai LifeSciences Holdings, Inc (MRVI)

Etorro trading 970x250
Maravai LifeSciences Holdings, Inc (MRVI) Logo

About Maravai LifeSciences Holdings, Inc

Maravai LifeSciences Holdings, Inc. operates as a life sciences company that provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases. The company’s products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in three segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry. The company serves biopharmaceutical companies, and other emerging biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California. Address: 10770 Wateridge Circle, San Diego, CA, United States, 92121

Maravai LifeSciences Holdings, Inc News and around…

Latest news about Maravai LifeSciences Holdings, Inc (MRVI) common stock and company :

56 Biggest Movers From Friday
29 Nov, 2021 FinancialContent

Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been ...

48 Stocks Moving In Friday's Mid-Day Session
26 Nov, 2021 FinancialContent

Gainers Allied Healthcare Products, Inc. (NASDAQ: AHPI) shares jumped 68% to $9.04. Shares of mask and protective apparel ...

Has LabCorp (LH) Outpaced Other Medical Stocks This Year?
24 Nov, 2021 Yahoo! Finance

Here is how LabCorp (LH) and Maravai LifeSciences Holdings, Inc. (MRVI) have performed compared to their sector so far this year.

IWP's Underlying Holdings Could Mean 11% Gain Potential
19 Nov, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Russell Mid-Cap Growth ETF (IWP), we found that the implied analyst target price for the ETF based upon its underlying holdings is $134.81 per unit.

Risks To Shareholder Returns Are Elevated At These Prices For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
17 Nov, 2021 Yahoo! Finance

Maravai LifeSciences Holdings, Inc.'s ( NASDAQ:MRVI ) price-to-earnings (or "P/E") ratio of 63.5x might make it look...

How Much Upside is Left in Maravai LifeSciences (MRVI)? Wall Street Analysts Think 40%
15 Nov, 2021 Yahoo! Finance

The consensus price target hints at a 40.2% upside potential for Maravai LifeSciences (MRVI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2021 Earnings Call Transcript
11 Nov, 2021 FinancialContent

MRVI earnings call for the period ending September 30, 2021.

Maravai LifeSciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance For 2022
10 Nov, 2021 Yahoo! Finance

SAN DIEGO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the third quarter ended September 30, 2021, together with other business updates. Highlights include: Revenue increased 133% to $204.8 million for the third quarter;Net income of $132.8 million for the third quarter, representing growth of 240% over the prior y

The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
10 Nov, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To ...

New England Biolabs® releases next generation HiScribe™ in vitro transcription kit, incorporating TriLink® Biotechnologies' CleanCap® technology for mRNA synthesis
08 Nov, 2021 Yahoo! Finance

New England Biolabs (NEB®) announced today that they have released a kit for the generation of in vitro transcribed synthetic mRNA capped using the TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), CleanCap Reagent AG.

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
08 Nov, 2021 FinancialContent

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good ...

92 Biggest Movers From Friday
08 Nov, 2021 FinancialContent

Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public ...

Maravai LifeSciences Holdings Becomes Oversold (MRVI)
05 Nov, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Maravai Lifesciences Shows Rising Relative Price Performance; Still Shy Of Key Benchmark
05 Nov, 2021 FinancialContent

A Relative Strength Rating upgrade for Maravai Lifesciences shows improving technical performance. Will it continue?

Maravai Lifesciences Earns IBD Rating Upgrade
03 Nov, 2021 FinancialContent

A Relative Strength Rating upgrade for Maravai Lifesciences shows improving technical performance. Will it continue?

Maravai LifeSciences Announces November 2021 Investor Conference Schedule
02 Nov, 2021 Yahoo! Finance

SAN DIEGO, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following virtual investor conferences during the month of November. On November 17, 2021, Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Stifel Healthcare Conference at 10:20 a.m. PT. On November 30, 2021, Kevin Herde, Chief Financial Officer, wil

Is Maravai LifeSciences Holdings, Inc. (MRVI) Going to Burn These Hedge Funds?
27 Oct, 2021 Yahoo! Finance

Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns. Hedge funds and institutional investors spend millions of dollars on analysts with MBAs and PhDs, who are industry experts and well connected to other industry and media insiders on top of that. Individual investors can piggyback […]

Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021
13 Oct, 2021 Yahoo! Finance

SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2021 financial and operating results after the market closes on Wednesday, November 10, 2021, and will host a conference call on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To participate in the conference call, dial (833) 693-0536 or (661) 407-1576 and enter the confere

Does This Valuation Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Imply Investors Are Overpaying?
07 Oct, 2021 Yahoo! Finance

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Maravai LifeSciences...

Maravai LifeSciences Expands its Intellectual Property Portfolio with European Patent
07 Oct, 2021 Yahoo! Finance

Advancement Expected to Further Accelerate Development of mRNA Vaccines and TherapeuticsSAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, announced today that the European Patent Office has issued a new patent, No. 3352584, to the company’s TriLink BioTechnologies subsidiary. The patent relates to TriLink’s CleanCap® technology for the co-transcriptional capping of

TriLink BioTechnologies® Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea
04 Oct, 2021 Yahoo! Finance

EyeGene expected to utilize TriLink’s CleanCap® technology and modified UTP manufactured by TriLink in the production of its EG-COVID mRNA COVID-19 vaccine for clinical trialsSAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- TriLink BioTechnologies (“TriLink”), a Maravai LifeSciences company (Nasdaq: MRVI) and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, announced today that it expects to supply its proprietary CleanCap® mRNA capping technology

54 Biggest Movers From Friday
04 Oct, 2021 FinancialContent

Check out these big penny stock gainers and losersLosers Spire Global, Inc.. (NYSE: SPIR) shares fell 43.3% to ...

Maravai LifeSciences Holdings is Now Oversold (MRVI)
01 Oct, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Maravai Lifesciences Stock Gets IBD Stock Rating Upgrade
30 Sep, 2021 Yahoo! Finance

Maravai Lifesciences saw its IBD SmartSelect Composite Rating rise to 97 Thursday, up from 94 the day before.

Maravai Lifesciences Gets IBD Stock Rating Upgrade
30 Sep, 2021 FinancialContent

Maravai Lifesciences saw its IBD SmartSelect Composite Rating rise to 97 Thursday, up from 94 the day before.

Maravai LifeSciences Holdings Larger Than S&P 500 Component NOV
21 Sep, 2021 FinancialContent

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Maravai LifeSciences Holdings Inc (MRVI) was identified as having a larger market cap than the smaller end of the S&P 500, for example NOV Inc (NOV), according to The Online Investor. Click here to find out the top S&P 500 components ordered by average analyst rating » Market capitalization is an important data point for investors to keep an eye on, for various reasons..

Top Biotech Stocks for Q4 2021
20 Sep, 2021 Yahoo! Finance

The biotechnology industry includes companies that develop drugs and diagnostic technologies for the treatment of diseases and medical conditions. This means that investors may wait for years before knowing whether a drug under development will pay off. Many biotech companies have shifted their focus entirely or added COVID-19 vaccine and treatments to their product pipeline.

Maravai Lifesciences Sees Composite Rating Move Up To 96
16 Sep, 2021 FinancialContent

On Thursday, Maravai Lifesciences got an upgrade for its IBD SmartSelect Composite Rating from 92 to 96.

Analysts Expect 10% Gains Ahead For IWP
15 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares Russell Mid-Cap Growth ETF (IWP), we found that the implied analyst target price for the ETF based upon its underlying holdings is $127.33 per unit.

60 Biggest Movers From Friday
13 Sep, 2021 FinancialContent

Gainers IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported ...

Maravai LifeSciences Holdings, Inc (MRVI) is a NASDAQ Common Stock listed in , ,

970x250